Stem Cells in Cardiovascular Medicine: the Road to Regenerative Therapies

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2017 Mar 22

PMID 28324469

Citations 1

Authors

Christopher W Anderson

Nicole Boardman

Jiesi Luo

Jinkyu Park

Yibing Qyang

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The purpose of this review is to provide a broad overview of current trends in stem cell research and its applications in cardiovascular medicine. Researches on different stem cell sources, their inherent characteristics, and the limitations they have in medical applications are discussed. Additionally, uses of stem cells for both modeling and treating cardiovascular disease are discussed, taking note of the obstacles these engineered interventions must overcome to be clinically viable.

Recent Findings: Tissue engineering aims to replace dysfunctional tissues with engineered constructs. Stem cell technologies have been a great enabling factor in working toward this goal. Many tissue-engineered products are in development that utilize stem cell technology. Although promising, some refinement must be made to these constructs with respect to safety and functionality. A deeper understanding of basic differentiation and tissue developmental mechanisms is required to allow these engineered tissues to be translated into the clinic.

Citing Articles

On-Chip Fabrication of Cell-Attached Microstructures using Photo-Cross-Linkable Biodegradable Hydrogel.

Takeuchi M, Kozuka T, Kim E, Ichikawa A, Hasegawa Y, Huang Q J Funct Biomater. 2020; 11(1).

PMID: 32183414 PMC: 7151615. DOI: 10.3390/jfb11010018.

References

Bobrow J . The ethics and politics of stem cell research. Trans Am Ophthalmol Soc. 2006; 103:138-41. PMC: 1447568. View

Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S . Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008; 26(11):1269-75. DOI: 10.1038/nbt.1502. View

Sun N, Panetta N, Gupta D, Wilson K, Lee A, Jia F . Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A. 2009; 106(37):15720-5. PMC: 2739869. DOI: 10.1073/pnas.0908450106. View

Patterson J, Gilliland T, Maxfield M, Church S, Naito Y, Shinoka T . Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again. Regen Med. 2012; 7(3):409-19. PMC: 3384697. DOI: 10.2217/rme.12.12. View

Scavone A, Capilupo D, Mazzocchi N, Crespi A, Zoia S, Campostrini G . Embryonic stem cell-derived CD166+ precursors develop into fully functional sinoatrial-like cells. Circ Res. 2013; 113(4):389-98. DOI: 10.1161/CIRCRESAHA.113.301283. View

McLaren A . Ethical and social considerations of stem cell research. Nature. 2001; 414(6859):129-31. DOI: 10.1038/35102194. View

Robertson M, Dries-Devlin J, Kren S, Burchfield J, Taylor D . Optimizing recellularization of whole decellularized heart extracellular matrix. PLoS One. 2014; 9(2):e90406. PMC: 3937369. DOI: 10.1371/journal.pone.0090406. View

Xue T, Cho H, Akar F, Tsang S, Jones S, Marban E . Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation. 2004; 111(1):11-20. DOI: 10.1161/01.CIR.0000151313.18547.A2. View

Hibino N, Yi T, Duncan D, Rathore A, Dean E, Naito Y . A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 2011; 25(12):4253-63. PMC: 3236622. DOI: 10.1096/fj.11-186585. View

10.

Del Alamo J, Lemons D, Serrano R, Savchenko A, Cerignoli F, Bodmer R . High throughput physiological screening of iPSC-derived cardiomyocytes for drug development. Biochim Biophys Acta. 2016; 1863(7 Pt B):1717-27. PMC: 4885786. DOI: 10.1016/j.bbamcr.2016.03.003. View

11.

Jackson K, Majka S, Wang H, Pocius J, Hartley C, Majesky M . Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107(11):1395-402. PMC: 209322. DOI: 10.1172/JCI12150. View

12.

Ma J, Both S, Yang F, Cui F, Pan J, Meijer G . Concise review: cell-based strategies in bone tissue engineering and regenerative medicine. Stem Cells Transl Med. 2013; 3(1):98-107. PMC: 3902295. DOI: 10.5966/sctm.2013-0126. View

13.

Salcedo R, Ponce M, Young H, Wasserman K, Ward J, Kleinman H . Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000; 96(1):34-40. View

14.

Itoh M, Kawagoe S, Tamai K, Okano H, Nakagawa H . Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with recessive dystrophic epidermolysis bullosa (RDEB) carrying two compound heterozygous mutations in the COL7A1 gene. Stem Cell Res. 2016; 17(1):32-35. DOI: 10.1016/j.scr.2016.05.003. View

15.

Lompre A, Mercadier J, Wisnewsky C, Bouveret P, Pantaloni C, DAlbis A . Species- and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev Biol. 2010; 84(2):286-90. DOI: 10.1016/0012-1606(81)90396-1. View

16.

Zhang X, Stojkovic P, Przyborski S, Cooke M, Armstrong L, Lako M . Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells. 2006; 24(12):2669-76. DOI: 10.1634/stemcells.2006-0377. View

17.

Bai H, Gao Y, Arzigian M, Wojchowski D, Wu W, Wang Z . BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. J Cell Biochem. 2009; 109(2):363-74. PMC: 3065830. DOI: 10.1002/jcb.22410. View

18.

Boyett M, Honjo H, Kodama I . The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res. 2000; 47(4):658-87. DOI: 10.1016/s0008-6363(00)00135-8. View

19.

Dash B, Levi K, Schwan J, Luo J, Bartulos O, Wu H . Tissue-Engineered Vascular Rings from Human iPSC-Derived Smooth Muscle Cells. Stem Cell Reports. 2016; 7(1):19-28. PMC: 4945325. DOI: 10.1016/j.stemcr.2016.05.004. View

20.

Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M . Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000; 6(2):88-95. PMC: 1949933. View